MFN deals force drug companies to lower prices in the U.S. by raising them in other countries
Is Trump’s most-favoured-nation drug policy keeping medicine from Canada? Evidence is mixed
TH
The Globe and Mail - BusinessBy Chris HannayEXECUTIVE SUMMARY
MFN deals force drug companies to lower prices in the U.S. by raising them in other countries
Key Takeaways
- Is Trump’s most-favoured-nation drug policy keeping medicine from Canada?
- MFN deals force drug companies to lower prices in the U.S.
- by raising them in other countries
Read Complete Original Article
Published originally on The Globe and Mail - Business



